Entrepreneurship runs in Jason Moore’s family. Long before the internet, his father, a self-taught programmer and engineer who grew up dirt poor in the shadow of Texas oil refineries, invented networking gear that for the first time let chain stores share data on sales and returns. It was clear early on that Moore shared his father’s gene for innovation. “I’ve been tinkering with business ideas pretty much since I was a teenager,” Moore says. “Lots of them were stupid, but it was all fun.” His best one from his college days: a forum of forums, which someone else turned into Reddit. He abandoned the idea after a roommate at the time said it would never work. But Moore, 35, persevered. In the last few years, he’s built two of the world’s most popular health apps: Spren and Elite HRV. Backed by 100 university research labs, Moore’s apps measure body fat, muscle, heart rate variability (HRV), and much more, using just the camera on a smartphone or a wearable monitor, like a $30 chest strap.
It started with HRV, a biomarker that measures imperceptible variations in heart beats. Research shows that high variability is a sign of good health, while low variability is associated with stress and fatigue, which can lead to injury. Moore learned that HRV is a reliable measure of how well the autonomic nervous system—the body’s main control grid—is functioning. HRV reveals the body’s response to exercise, illness, inflammation, stress, and mental health. Moore’s company, Spren, based in Asheville, North Carolina, has expanded from HRV into other markers.

Spren’s tool uses digital photos to determine composition of fat and lean muscle. The key is a Spren algorithm that compares the photos to vast databases built with more costly, invasive measures of body fat, like caliper measurements, X-ray scans, and underwater weighing. Venture capitalists have taken notice. Ideaship, a venture fund in Portland, Oregon, that provides patent expertise in exchange for equity stakes in young companies, signed with Spren in 2019. In 2022 it made a cash follow-on investment as part of Spren’s $11 million seed raise. “Spren is changing the way health-conscious people improve their fitness,” said Michael Lubitz, Ideaship’s Founder and Managing Director. “Larger companies are eyeing biomarkers for their health applications and we’re pretty certain that Spren is on their radar.” Moore wanted patent protection for his technology, but, as a startup, he didn’t have the tens of thousands of dollars it takes to do patents right. Enter Ideaship and its parent company, Global Technology Transfer Group.

GTT Group has been advising multinational companies on their core patent strategy for more than 25 years. In 2018, it partnered with Panasonic Intellectual Property Corp. of America to form Ideaship and leverage its expertise as an in-kind venture capitalist. “Patents are expensive things for small startups to spend precious money on, but they can make a huge difference in their valuations and exit price” says GTT Group Managing Director Tyler McKinley. “We created Ideaship to help startups protect and leverage their true value.” Ideaship worked with Moore to patent the technology behind Spren, which, over time and through many iterations, had become its most valuable asset. Lubitz saw that the proper patents could protect Spren from copycats and show larger companies that Spren was “prophetic,” a term he uses to describe startup companies that own groundbreaking intellectual property, ensuring that the path forward for any competitor leads through them. “Owning the IP that drives the business creates leverage and drives up valuations,” Lubitz says.
Moore partnered with Ideaship to do the foundational patent-strategy work that is the hallmark of the fund’s in-kind investment. A deep bench of patent analysis and subject matter experts from Ideaship and GTT Group worked with Moore to hone his patents, first on a piece of hardware to measure HRV more accurately, and then on the smart-phone-based system. Just as important: Ideaship helped Moore determine the true value of his team’s innovations. Ideaship uses a proprietary investment protocol that captures and documents patentable innovations and creates a roadmap for building the IP portfolio. Ideaship analyzes patent activity to identify acquirers and computes patent valuations in a way that substantiates their worth to investors. The data supports Moore’s decision to seek patents sooner rather than later. Startups seeking patents raise more capital than their non-patent-seeking peers, according to a February 2023 report from Pitchbook Data Inc.
Between 2011 and 2020, deal sizes for patent seeking startups were 40% to 60% larger than those for non-patent startups, Pitchbook said. Angel investments showed the largest difference: investments in patent seeking startups were almost twice as large. Spren got another vote of confidence in July, 2022, when Drive by DraftKings, a venture firm backed by DraftKings, the Boston-based sports betting company, led Spren’s seed round. Drive’s other investors include General Catalyst, Accomplice and Boston Seed Capital.
Moore’s idea for Spren germinated when he was doing something distinctly non-entrepreneurial. After graduating from Texas A&M University with a degree in information and operations management, he went to work at Marathon Oil Co. in Houston. The job taught him the value of measurement and data. He worked on a team that analyzed gigabytes of sensor data from Marathon’s oilfield equipment to optimize its performance. He became an expert in SAP, the powerful— and notoriously difficult—business software.
“We were saving lives—and billions of dollars—by doing preventive maintenance,” Moore says. Start-up fever still gripped Moore while he sat at his desk. A soccer player in college, he renewed his interest in fitness. His parents struggled with their weight, and he felt like he was slowing down. Never one to do anything at half speed, Moore became a health and fitness instructor on the side. “I went down the rabbit hole on different things you can measure about the body,” Moore says. That led him to HRV. At the time, only leading-edge researchers and coaches were using it, mostly as a warning sign for injury. Moore’s roommate at the time was a coder, and Moore convinced him to help write an app that would track HRV using chest-strap heart monitors. In 2014, they each put $500 in a bank account and went for it. They called the app Elite HRV and made it free. Two months later, they had 1,000 users.
The app spread by word of mouth. A few months later, Scotland’s national rugby team called and asked Moore to come to Edinburgh to talk about HRV. A year after launch, Elite HRV had 18,000 users. Moore communicated with thousands of them on nights and weekends. In the middle of it all, Moore married Alyssa Barker, an engineer at Marathon who worked at an in-house startup. They spent a year traveling the world. At many stops, they met with people about HRV. On the way home from Asia, they stopped at the UCSF Benioff Children’s Hospital in Oakland, California, and talked to counselors there about how HRV changed when kids were being abused. Children are good at hiding stress, Moore learned, and HRV gave doctors and parents a new window into the ill-effects on their bodies and minds. “Kids have lots of health issues from the trauma underneath the surface, and you can’t see it from the outside because they learn to stay stone faced,” Moore says.


Seeing those kids convinced Moore that he had to turn his app into a company to pursue further biomarker research. He and Alyssa settled in Asheville in 2017 and went to work. They did a Kickstarter campaign that raised $191,352, becoming one of the biggest ever in North Carolina. They also recruited a third co-founder, Vivek Menon, who worked at a renal care company called NxStage before it was purchased for $2 billion by Fresenius Medical Care. They used the money to make a piece of hardware: their own, professional-grade pulse oximeter. It came out in 2018, and they sold 20,000 of them in 80 countries. All of a sudden, they had a profitable company with $1 million in annual revenue and no outside investors, beyond Kickstarter. Moore and the team knew they could help even more people. So, despite being an introvert by nature, he wentout to pitch investors. The process revealed flaws. Their hardware wasn’t scalable, and their secret sauce was interpreting existing data streams. They decided to drop the hardware business and hire a PhD from the University of Maryland with expertise in computer vision and signal processing so they could track HRV using the cameras on smartphones.
“Our main revenue source was our hardware, and here we were innovating a software solution to replace it,” Moore says. “But our mission was to make this more accessible to more people.” The raise supported Spren’s strategic decision to stop developing proprietary hardware and instead use smartphones and chest straps, which fueled meteoric growth to more than 800,000 users. The company branched out to track sleep, exercise, blood pressure, blood glucose, and, now, body fat. With Spren, users snap a few pictures to get accurate
percentages of body fat and muscle. It works because Spren benchmarked its algorithm against DEXA (X-Ray), underwater weighing, and bioimpedance technologies across thousands of people. “We used the gold standards that you had to go to a lab to get—until now,” Moore says. As a committed long-term partner, Ideaship has supported Spren through pivots and iterations, run interference with the US Patent & Trade Office, and leveraged GTT Group’s talented team for advanced consultations and nuanced advice. “Ideaship invests in companies that are literally building the future on which we’ll all rely, and we help them fiercely defend and capture the value of those innovations in the marketplace,” Ideaship’s Lubitz says. “In my mind that is the definition of a strategic investor.”